Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-014411
Filing Date
2017-07-28
Accepted
2017-07-28 16:59:22
Documents
41
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crxm-10q_20170331.htm 10-Q 755769
2 EX-31.1 crxm-ex311_289.htm EX-31.1 10179
3 EX-31.2 crxm-ex312_288.htm EX-31.2 10181
4 EX-32 crxm-ex32_290.htm EX-32 5503
  Complete submission text file 0001564590-17-014411.txt   2568971

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crxm-20170331.xml EX-101.INS 343230
6 XBRL TAXONOMY EXTENSION SCHEMA crxm-20170331.xsd EX-101.SCH 25758
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crxm-20170331_cal.xml EX-101.CAL 22498
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crxm-20170331_def.xml EX-101.DEF 90281
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crxm-20170331_lab.xml EX-101.LAB 200241
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crxm-20170331_pre.xml EX-101.PRE 159566
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Taxus Cardium Pharmaceuticals Group Inc. (Filer) CIK: 0000772320 (see all company filings)

EIN.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33635 | Film No.: 17990711
SIC: 2836 Biological Products, (No Diagnostic Substances)